Open AccessLiposomal bupivacaine does not decrease postoperative opioid use or length of hospital stay in patients undergoing anterior cervical discectomy and fusion
Author(s) -
Eric V. Neufeld,
TP Ng,
Benjamin C. Schaffler,
Cesar Iturriaga,
Amiram Katz,
Alan Job,
Christopher Petersen,
Dean C. Perfetti,
Rohit Verma
Publication year - 2022
Publication title -
journal of spine surgery
Language(s) - English
Resource type - Journals
eISSN - 2414-469X
pISSN - 2414-4630
DOI - 10.21037/jss-22-34
Subject(s) - medicine , anterior cervical discectomy and fusion , anesthesia , discectomy , opioid , surgery , cervical spine , lumbar , receptor
Despite its widespread use, definitive data demonstrating the efficacy of liposomal bupivacaine (LB) is limited especially in patients undergoing anterior cervical discectomy and fusion (ACDF). Therefore, this investigation examined whether ACDF patients who received intra-operative LB (LB cohort) exhibited decreased post-operative opioid use and lengths of hospital stay (LOS) compared to ACDF patients who did not receive intra-operative LB (controls).